Sangamo Biosciences, Inc. (SGMO) Posts Q1 Loss of 12c/Share

Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $8.1 million versus the consensus estimate of $6.59 million.

For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$625 at Benchmark to Reflect Downward Earnings Revisions
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c